A report by a parliamentary committee has shown that the drug industry regulator, the Drug Controller General of India (DCGI), has been approving, on average, one new drug a month without conducting mandatory clinical trials or seeking expert medical opinion—findings that expose the deep flaws prevalent in India’s drug approval process. The committee has asked the health ministry to withdraw the discretionary powers given to the Central Drugs Standard Control Organization...

I have not read the Private Member's Bill on media regulation that Meenakshi Natarajan was scheduled to move in Parliament last week so I am not in a position to comment upon it, but I am certainly of the opinion that the media (both print and electronic) needs to be regulated. Since my ideas on this issue have generated some controversy they need to be clarified. I want regulation of the...

The National Advisory Council has asked the Centre to formulate a national policy to stem the declining sex ratio at birth that it believed was “located at the complex interface of the status of women in Indian society, patriarchal social mores and prejudice, spread and misuse of medical technology and the changing aspirations of urban and rural society”. The council’s draft recommendations — prepared by members Farah Naqvi and A.K. Shiva...

-HealthIndia.com To improve the rural health scenario the government intends to introduce the Bachelor of Rural Healthcare course (BRHC), which will require all medical students to work in rural areas for a period of time. This will see a change in the Postgraduate Medical education guidelines, which will include a 50% reservation quota for medical officers in government service. Also as an added incentive, there will be a 10% increase in...

-The Telegraph An Indian pharmaceutical company has tweaked and tested a synthetic molecule first created in an American university and developed the world's latest drug against malaria, an alternative to standard anti-malarial therapy. India’s Ranbaxy Laboratories today launched the new drug for the treatment of uncomplicated malaria caused by the Plasmodium falciparum parasite, after nine years of research which was partly supported by the Indian government. Clinical trials in India, Tanzania, and Thailand...